Search

Showing "11155" results for ""

Raltegravir versus efavirenz in treatment-naïves at 96 weeks: continued efficacy and fewer adverse effects

Treatment outcomes in Latin America, China and Botswana: successes and shortfalls

Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy

Circumcision will halve HIV rates but may take decades to reach full impact

Prevention – there will be no magic bullet, we need ‘combination prevention’

AIDS in 2031: where will we be?

Major prevention success for sex workers and men who have sex with men in India

Urine biomarkers may predict cardiovascular disease in people taking antiretroviral therapy

New TB/HIV guidelines released to improve care and treatment of drug users

Skills-building behavioural interventions advocated for reducing alcohol-related HIV risk in South Africa

Criminal HIV transmission and exposure laws spreading around the world ‘like a virus’

Treatment as prevention tool: enough evidence to say it works, says IAS president

Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells

Tenofovir kidney toxicity most likely with high blood pressure medications and PIs

Which gay men should be the target for prevention work?

Two new NNRTIs look promising in early clinical trials

SMART study and 54-trial pooled analysis produce conflicting data about abacavir heart attack link

Systematic review unable to confirm or deny Swiss statement on infection risk with undetectable viral load

Receive the latest HIV research and conference news

Showing "11155" results for ""

Raltegravir versus efavirenz in treatment-naïves at 96 weeks: continued efficacy and fewer adverse effects

Treatment outcomes in Latin America, China and Botswana: successes and shortfalls

Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy

Circumcision will halve HIV rates but may take decades to reach full impact

Prevention – there will be no magic bullet, we need ‘combination prevention’

AIDS in 2031: where will we be?

Major prevention success for sex workers and men who have sex with men in India

Urine biomarkers may predict cardiovascular disease in people taking antiretroviral therapy

New TB/HIV guidelines released to improve care and treatment of drug users

Skills-building behavioural interventions advocated for reducing alcohol-related HIV risk in South Africa

Criminal HIV transmission and exposure laws spreading around the world ‘like a virus’

Treatment as prevention tool: enough evidence to say it works, says IAS president

Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells

Tenofovir kidney toxicity most likely with high blood pressure medications and PIs

Which gay men should be the target for prevention work?

Two new NNRTIs look promising in early clinical trials

SMART study and 54-trial pooled analysis produce conflicting data about abacavir heart attack link

Systematic review unable to confirm or deny Swiss statement on infection risk with undetectable viral load

Receive the latest HIV research and conference news